UK | August 2025 | FA-11422383

This non-promotional advert has been funded and created by Novartis Pharmaceuticals UK Limited for UK healthcare professionals.

Elevated lipoprotein(a) [Lp(a)] 

is an inherited, independent 

and causal risk factor for

cardiovascular disease.¹

References:

1 Enas EA, et al. Indian Heart J. 2019 Mar-Apr;71(2):99-112.

2 Kamstrup et al. J Am Coll Cardiol 2013;61:1146–1156

3 Wilson et al. J Clin Lipidol. 2019;13(3):374–392

It is associated with 

increased risk of:

• Myocardial infarction²

• Ischemic stroke³

• Aortic valve stenosis³

• Peripheral arterial disease³

Explore the 

latest evidence 

on the impact of 

elevated Lp(a) at

lipoproteina.co.uk.

Find out more

This non-promotional advert has been funded and created by Novartis Pharmaceuticals UK Limited for UK healthcare professionals.